In-Silico Structure Database (LMISSD)
BackLMISSD: Lipid Classification search results
Fatty Acyls [FA](W) --> Docosanoids [FA04] --> Neuroprostanes [FA0401]
LM_ID | Common Name | Systematic Name | Formula | Mass |
---|---|---|---|---|
LMFA04010504 | ent-7,14-diepi-14-J4-NeuroP | (Z)-6-((1S,5R)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid | C22H30O4 | 358.2144 |
LMFA04010505 | 7-epi-14-J4-NeuroP | (Z)-6-((1R,5S)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid | C22H30O4 | 358.2144 |
LMFA04010506 | ent-14-epi-14-J4-NeuroP | (Z)-6-((1R,5R)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid | C22H30O4 | 358.2144 |
LMFA04010507 | 17-epi-17-J4-NeuroP | (4Z,7Z)-9-((1S,5S)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid | C22H30O4 | 358.2144 |
LMFA04010508 | ent-10-epi-17-J4-NeuroP | (4Z,7Z)-9-((1S,5R)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid | C22H30O4 | 358.2144 |
LMFA04010509 | 10,17-diepi-17-J4-NeuroP | (4Z,7Z)-9-((1R,5S)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid | C22H30O4 | 358.2144 |
LMFA04010510 | ent-17-J4-NeuroP | (4Z,7Z)-9-((1R,5R)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid | C22H30O4 | 358.2144 |
LMFA04010511 | 17-J4-NeuroP | (4Z,7Z)-9-((1S,5S)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid | C22H30O4 | 358.2144 |
LMFA04010512 | ent-10,17-diepi-17-J4-NeuroP | (4Z,7Z)-9-((1S,5R)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid | C22H30O4 | 358.2144 |
LMFA04010513 | 10-epi-17-J4-NeuroP | (4Z,7Z)-9-((1R,5S)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid | C22H30O4 | 358.2144 |
LMFA04010514 | ent-17-epi-17-J4-NeuroP | (4Z,7Z)-9-((1R,5R)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid | C22H30O4 | 358.2144 |
LMFA04010515 | 20-epi-20-J4-NeuroP | (4Z,7Z,10Z)-12-((1S,5S)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid | C22H30O4 | 358.2144 |
LMFA04010516 | ent-13-epi-20-J4-NeuroP | (4Z,7Z,10Z)-12-((1S,5R)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid | C22H30O4 | 358.2144 |
LMFA04010517 | 13,20-diepi-20-J4-NeuroP | (4Z,7Z,10Z)-12-((1R,5S)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid | C22H30O4 | 358.2144 |
LMFA04010518 | ent-20-J4-NeuroP | (4Z,7Z,10Z)-12-((1R,5R)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid | C22H30O4 | 358.2144 |
LMFA04010519 | 20-J4-NeuroP | (4Z,7Z,10Z)-12-((1S,5S)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid | C22H30O4 | 358.2144 |
LMFA04010520 | ent-13,20-diepi-20-J4-NeuroP | (4Z,7Z,10Z)-12-((1S,5R)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid | C22H30O4 | 358.2144 |
LMFA04010521 | 13-epi-20-J4-NeuroP | (4Z,7Z,10Z)-12-((1R,5S)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid | C22H30O4 | 358.2144 |
LMFA04010522 | ent-20-epi-20-J4-NeuroP | (4Z,7Z,10Z)-12-((1R,5R)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid | C22H30O4 | 358.2144 |